382 related articles for article (PubMed ID: 37175871)
1. Cell Therapy as Target Therapy against Colon Cancer Stem Cells.
Garza Treviño EN; Quiroz Reyes AG; Rojas Murillo JA; de la Garza Kalife DA; Delgado Gonzalez P; Islas JF; Estrada Rodriguez AE; Gonzalez Villarreal CA
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175871
[TBL] [Abstract][Full Text] [Related]
2. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
3. Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.
Luna JI; Grossenbacher SK; Murphy WJ; Canter RJ
Expert Opin Biol Ther; 2017 Mar; 17(3):313-324. PubMed ID: 27960589
[TBL] [Abstract][Full Text] [Related]
4. Cancer Stem Cells and their Management in Cancer Therapy.
Shenouda S; Kulkarni K; Abuetabh Y; Sergi C
Recent Pat Anticancer Drug Discov; 2020; 15(3):212-227. PubMed ID: 32660407
[TBL] [Abstract][Full Text] [Related]
5. The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remission.
Kopenhaver J; Crutcher M; Waldman SA; Snook AE
Expert Opin Biol Ther; 2021 Oct; 21(10):1335-1345. PubMed ID: 33977849
[No Abstract] [Full Text] [Related]
6. Suppressive effect of α-mangostin for cancer stem cells in colorectal cancer via the Notch pathway.
Jo MK; Moon CM; Kim EJ; Kwon JH; Fei X; Kim SE; Jung SA; Kim M; Mun YC; Ahn YH; Seo SY; Kim TI
BMC Cancer; 2022 Mar; 22(1):341. PubMed ID: 35351071
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic diiminoquinone exhibits anticancer effects on human colorectal cancer cells in two-dimensional and three-dimensional
Monzer A; Wakimian K; Ballout F; Al Bitar S; Yehya A; Kanso M; Saheb N; Tawil A; Doughan S; Hussein M; Mukherji D; Faraj W; Gali-Muhtasib H; Abou-Kheir W
World J Gastroenterol; 2022 Sep; 28(33):4787-4811. PubMed ID: 36156922
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
[TBL] [Abstract][Full Text] [Related]
9. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
11. Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer.
Shaheen S; Ahmed M; Lorenzi F; Nateri AS
Stem Cell Rev Rep; 2016 Aug; 12(4):492-9. PubMed ID: 27207017
[TBL] [Abstract][Full Text] [Related]
12. Targeted immunotherapy to cancer stem cells: A novel strategy of anticancer immunotherapy.
Yi SY; Wei MZ; Zhao L
Crit Rev Oncol Hematol; 2024 Apr; 196():104313. PubMed ID: 38428702
[TBL] [Abstract][Full Text] [Related]
13. Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis.
Singh D; Khan MA; Siddique HR
Biochem Pharmacol; 2022 Apr; 198():114955. PubMed ID: 35181312
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell therapy targeting cancer stem cells: Old wine in a new bottle.
Guo F; Zhang Y; Bai L; Cui J
Cancer Lett; 2023 Aug; 570():216328. PubMed ID: 37499742
[TBL] [Abstract][Full Text] [Related]
15. miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence.
Osaki M; Okada F; Ochiya T
Ther Deliv; 2015 Mar; 6(3):323-37. PubMed ID: 25853308
[TBL] [Abstract][Full Text] [Related]
16. The role of stem cells in small-cell lung cancer: evidence from chemoresistance to immunotherapy.
Guo W; Qiao T; Li T
Semin Cancer Biol; 2022 Dec; 87():160-169. PubMed ID: 36371027
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells.
Morita R; Nishizawa S; Torigoe T; Takahashi A; Tamura Y; Tsukahara T; Kanaseki T; Sokolovskaya A; Kochin V; Kondo T; Hashino S; Asaka M; Hara I; Hirohashi Y; Sato N
Cancer Sci; 2014 Apr; 105(4):389-95. PubMed ID: 24450541
[TBL] [Abstract][Full Text] [Related]
18. Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy.
Borlongan MC; Saha D; Wang H
Stem Cell Rev Rep; 2024 Jan; 20(1):3-24. PubMed ID: 37861969
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis.
Kapoor-Narula U; Lenka N
Cytokine; 2022 Sep; 157():155968. PubMed ID: 35872504
[TBL] [Abstract][Full Text] [Related]
20. Targeting Stemness: Implications for Precision Medicine in Breast Cancer.
Liang ZM; Chen Y; Luo ML
Adv Exp Med Biol; 2017; 1026():147-169. PubMed ID: 29282683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]